Summary
- Current Price
- As of today, PASG price is $5.00, up +0.30% on
- Current Price All-Time High
- PASG price is currently -99.35% below its historical high of $764.60 set on
- Market Cap
- PASG current market cap is $16M, down -27.38% year-over-year
- Revenue
- PASG current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for PASG has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Passage Bio, Inc. |
| Ticker | NASDAQ: PASG |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | passagebio.com |
| Employees | 60 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $5.00 | ||
| Price, 1D Change | +0.30% | |
| $16M | ||
| - | ||
| - | ||
| 2.71 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$14.35 | ||
| EPS, 1Y Change | +33.09% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$14.35 | ||
| EPS Estimate | -$11.34 | N/A |
| EPS Est. Change | +20.96% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $5.00 | ||
| Price Target | $15.50 | - |
| Price Tgt. Change | +210.00% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.83 | -$21.44 | -2,499.30% | |
| -$11.17 | -$14.35 | -28.47% | |
| -$11.34 | N/A | +20.96% | |
| -$10.39 | N/A | +27.58% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -28.26% | ||
| -67.11% | ||
| -27.38% | ||
| -98.07% | ||
| 0.00% | ||
| 0.00% | ||
| +33.09% | ||
| -473.66% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $5.00 | ||
| $7.54 | ||
| $4.64 | ||
| $6.55 | ||
| $4.80 | ||
| $0.07 | ||
| 2.71 | ||
| $0.30 | ||
| 61.35 | ||
| 38.42% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$14.35 | ||
| -$728.00K | ||
| - | ||
| -$43.15M | ||
| - | ||
| -$45.52M | ||
| - | ||
| -$42.42M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 1.28 | ||
| 2.07 | ||
| 2.07 | ||
| - | ||
| - | ||
| -17.43 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 3.61 | ||
| 0.21 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $18.76M | ||
| $46.30M | ||
| $62.28M | ||
| $47.76M | ||
| $43.53M | ||
| $23.08M | ||
| $24.01M | ||
| $3.57M | ||
| $1.11M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $45.52M | ||
| $42.42M | ||
| $728.00K | ||
| $0.00 | ||
| $728.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$31.51M | ||
| $40.22M | ||
| $23.00K | ||
| $0.00 | ||
| -$31.51M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wedbush | → | |
| TD Cowen | → | |
| Oppenheimer | → | |
| Chardan Capital | → | |
| Oppenheimer | ||
| Canaccord Genuity | → | |
| Chardan Capital | → | |
| Guggenheim | → | |
| Canaccord Genuity | → | |
| Wedbush | → |
Analyst sentiment
Institutional ownership
No data
Screeners with PASG
FAQ
- What is the ticker symbol for Passage Bio, Inc.?
- The ticker symbol for Passage Bio, Inc. is NASDAQ:PASG
- Does Passage Bio, Inc. pay dividends?
- No, Passage Bio, Inc. does not pay dividends
- What sector is Passage Bio, Inc. in?
- Passage Bio, Inc. is in the Healthcare sector
- What industry is Passage Bio, Inc. in?
- Passage Bio, Inc. is in the Biotechnology industry
- What country is Passage Bio, Inc. based in?
- Passage Bio, Inc. is headquartered in United States
- When did Passage Bio, Inc. go public?
- Passage Bio, Inc. initial public offering (IPO) was on February 28, 2020
- Is Passage Bio, Inc. in the S&P 500?
- No, Passage Bio, Inc. is not included in the S&P 500 index
- Is Passage Bio, Inc. in the NASDAQ 100?
- No, Passage Bio, Inc. is not included in the NASDAQ 100 index
- Is Passage Bio, Inc. in the Dow Jones?
- No, Passage Bio, Inc. is not included in the Dow Jones index
- When was Passage Bio, Inc. last earnings report?
- Passage Bio, Inc.'s most recent earnings report was on March 3, 2026
- When does Passage Bio, Inc. report earnings?
- The date for Passage Bio, Inc.'s next earnings report has not been announced yet
Data Sources & References
- PASG Official Website www.passagebio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1787297/000110465926022549/0001104659-26-022549-index.htm
- PASG Profile on Yahoo Finance finance.yahoo.com/quote/PASG
- PASG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pasg
